Bain Capital Life Sciences
Investor profile
Venture capital
Bain Capital Life Sciences has backed 2 European tech companies across 2 funding rounds between 2023 and 2026, joining rounds totalling €333M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2023–2026
4 yrs
Total round €
€333M
sum of rounds joined
Deals by year
distinct rounds / yearBain Capital Life Sciences — deals by year — interactive chart.
Data table
| Bain Capital Life Sciences — deals by year | |
|---|---|
| 2023 | 1 |
| 2026 | 1 |
Top sectors
by dealsBain Capital Life Sciences — top sectors — interactive chart.
Data table
| Bain Capital Life Sciences — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsBain Capital Life Sciences — stages — interactive chart.
Data table
| Bain Capital Life Sciences — stages | |
|---|---|
| Series A | 1 |
| Series C | 1 |
Countries
by dealsBain Capital Life Sciences — countries — interactive chart.
Data table
| Bain Capital Life Sciences — countries | |
|---|---|
| UK | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €273M |
| EyeBiotech | UK | 1 | €61M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| EyeBiotech | Series A | €61M | 2023-11 |